NEW YORK, Feb 27 – Illumina of San Diego said Tuesday it had penned a deal with Chevron Research and Technology to study ways Illumina’s fiber-optic BeadArray microarray technology could be used to detect compounds in chemical plant operations.

Chevron, which is funding the study, expects to complete the research by early 2002. Chevron previously invested in Illumina through its venture capital group.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.